Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activation - Wikidata - awgldk - TriplyDB

Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activation

Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activation

http://www.wikidata.org/entity/Q28263653

about

TRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis induction A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells Overexpression of the Notch target genes Hes in vivo induces lymphoid and myeloid alterations Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions Roles of TRAF3 in T cells: many surprises Pleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) family 4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity Solving the genetic puzzle of systemic lupus erythematosus.OX40 stimulation by gp34/OX40 ligand enhances productive human immunodeficiency virus type 1 infection.Intermittent and sustained hypoxia induce a similar gene expression profile in human aortic endothelial cells.Control of immunity by the TNFR-related molecule OX40 (CD134)The adaptor TRAF5 limits the differentiation of inflammatory CD4(+) T cells by antagonizing signaling via the receptor for IL-6.Activation of OX40 augments Th17 cytokine expression and antigen-specific uveitis.Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cells The significance of OX40 and OX40L to T-cell biology and immune disease.TNF-receptor-associated factors as targets for drug development.Agonist antibodies to TNFR molecules that costimulate T and NK cells TNF superfamily protein-protein interactions: feasibility of small- molecule modulation Basophil-associated OX40 ligand participates in the initiation of Th2 responses during airway inflammation An alternative signal 3: CD8⁺ T cell memory independent of IL-12 and type I IFN is dependent on CD27/OX40 signaling.Regulation of the PKCθ-NF-κB Axis in T Lymphocytes by the Tumor Necrosis Factor Receptor Family Member OX40 Activation of NF-kappaB by HTLV-I and implications for cell transformation.TRAF5-mediated Lys-63-linked Polyubiquitination Plays an Essential Role in Positive Regulation of RORγt in Promoting IL-17A Expression Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4+ T cells.Activation of NF-kappaB1 by OX40 contributes to antigen-driven T cell expansion and survival.Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer.TRAF molecules in cell signaling and in human diseases TNF receptor-associated factor 5 is required for optimal T cell expansion and survival in response to infection TRAF4, at the Crossroad between Morphogenesis and Cancer.TNF superfamily: costimulation and clinical applications The role of OX40-mediated co-stimulation in T-cell activation and survival.Soluble OX40L and JAG1 Induce Selective Proliferation of Functional Regulatory T-Cells Independent of canonical TCR signaling The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy.T cell co-stimulatory molecules: a co-conspirator in the pathogenesis of eosinophilic esophagitis?Regulation of PI-3-Kinase and Akt Signaling in T Lymphocytes and Other Cells by TNFR Family Molecules The contextual role of TNFR family members in CD8(+) T-cell control of viral infections.Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.Regulatory tone and mucosal immunity in asthma OX40, OX40L and Autoimmunity: a Comprehensive Review.Harnessing co-stimulatory TNF receptors for cancer immunotherapy: Current approaches and future opportunities.

P2860

Q22010633-8D0BC05A-856D-4E9C-94AA-DA7A5C2F8E73 Q24291798-54FA9EA7-4212-44EB-A729-83083B044F7A Q24298328-DCBF4F53-9E1D-4CC6-8B12-237BBA2F58A8 Q26853280-8864AC45-4374-4DCD-BEF5-1ED20FCEFCD6 Q27023925-DFB8248A-0807-4502-9036-9217FB786DB1 Q28208696-EBE4BD00-1603-431D-8F45-73EE464F7324 Q28217502-03D4C6E6-D455-45B3-8A21-92736DA7651A Q33359121-AF8E6994-6C14-4D9D-81CD-56D459C4DB02 Q33844046-6A5EECAD-EBC9-4A0B-9D89-B53F5F93BE33 Q33847657-1EFA827A-DA39-4638-B96C-292E797D7D0C Q33899607-E564DE2B-0942-44BB-9EEF-A85ED9E28071 Q33940420-F65B7C43-0A80-427D-B98C-33EDD3B27B4F Q34358363-98CA8592-E6CD-4921-A163-BE2CD39BC50C Q34582700-60D03629-3BEC-4460-B2AF-AB9D8CD31477 Q34979946-97FAC143-0935-4D9A-B92A-34AFCE4FF5A5 Q35143919-BB24A0AD-BA53-44CC-ACEE-138F67D56871 Q35427446-EE524A2C-2C51-45FE-97C6-3A19D7DC08AF Q35534271-7FB22EAE-1180-4E10-B663-B5B86C1C301D Q35608058-8E313A37-842A-4860-9642-C95130514E13 Q35717963-9806BDF6-3287-4E23-A0C0-BF4F49AF9B68 Q35990308-C20ED772-3673-4265-9EBC-824729210726 Q36254865-B154256D-AC1F-4F6D-AF87-90EEC6F45F6C Q36323541-F9381808-C4FD-4AB8-9B8C-3B053C7A2239 Q36370648-1E2EB074-44EB-4E26-997C-A43561E3097C Q36696891-9895C6C0-73E8-4E0D-B3C3-21073D4252E4 Q36851678-2FACC8C7-B131-49B4-B916-F49A0CC646C6 Q36972287-9C10488E-D44D-4000-A4A5-161636E95724 Q37085756-6B3CC5C3-840F-4585-9DC8-FC832A88E4FD Q37132817-58D34797-2588-426D-A01D-51CED8E46DE1 Q37266849-A1E87120-DFF9-4221-BF84-17CB3301A9BC Q37524064-3D861A7C-5FE4-4AC4-90B0-AE9C10093C0A Q37550184-A5F49ED2-9960-40FA-BAE9-A63A803DB27A Q38081999-931D06E4-B2FD-40BF-AF3A-DD977AA50CCD Q38086114-5601C6D8-65F8-4417-8F51-6AE6B12D5357 Q38113962-DA9142ED-FCC3-4954-8D6E-5140758DC548 Q38129083-26B0A51C-B614-4E90-BDE4-B9003E718A8C Q38179139-030CCE23-8545-474E-BE00-136D487C516C Q38224322-C61FB40E-399D-488C-A00A-1A7503F07573 Q38555213-44D282E3-57C8-4B40-8E16-E5F3447BBA94 Q38770814-115C835D-23CA-408F-B55F-1DC3338B7E54

P2860

Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activation

http://www.wikidata.org/entity/Q28263653

description

1998 nî lūn-bûn

@nan

1998 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի մարտին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Activation of OX40 signal tran ...... -mediated NF-kappaB activation

@ast

Activation of OX40 signal tran ...... -mediated NF-kappaB activation

@en

Activation of OX40 signal tran ...... -mediated NF-kappaB activation

@nl

type

label

Activation of OX40 signal tran ...... -mediated NF-kappaB activation

@ast

Activation of OX40 signal tran ...... -mediated NF-kappaB activation

@en

Activation of OX40 signal tran ...... -mediated NF-kappaB activation

@nl

prefLabel

Activation of OX40 signal tran ...... -mediated NF-kappaB activation

@ast

Activation of OX40 signal tran ...... -mediated NF-kappaB activation

@en

Activation of OX40 signal tran ...... -mediated NF-kappaB activation

@nl

P1433

Q28263653-E21E5543-525C-4BEC-A0EF-CDA63AEBEC7F

P1476

Q28263653-B7E921BD-9D80-4219-94C5-E17075191FCE

P2093

Q28263653-15D66975-0942-46E1-9E99-6E8DE70217B0

Q28263653-4727E282-A398-45A5-B53B-4B0B630A5393

Q28263653-9BDEB06B-942B-43F3-BE11-83731E59B147

Q28263653-C1A34D19-3E81-4443-B75C-96A962B09A1F

Q28263653-EA5A82AD-B6A1-4424-8334-4C34DD44D51F

P2860

Q28263653-0C9D1FFE-1712-4FFA-9992-87B3E84862E1

Q28263653-0D01046E-EFA5-41A9-ADF0-F9404C43E505

Q28263653-2A45E194-0998-49E3-A2F9-E7BA7F468980

Q28263653-2EF911CD-95D7-4FB2-AC2C-C47AEC964595

Q28263653-3120C10D-0017-40E5-B07E-DB1168A78356

Q28263653-36BDB31A-197C-4FAD-85E1-B7DFD990AB7A

Q28263653-36CE49C4-5230-45A0-941C-80FA8B2A3FEF

Q28263653-3BB1F4E2-6360-4B19-A3BA-F2D5E124F583

Q28263653-3BE9523C-8AD8-4F54-BF7A-D9DC41E13B58

Q28263653-48ADCE08-C6B2-4926-B5B9-5032AD6ACC59

P304

Q28263653-2D023712-B8B1-4364-8717-631B69341E7C

P31

Q28263653-F737CA6F-EA82-40C6-9DCC-90FC61D84AA8

P356

Q28263653-02DEC3AA-36A6-4CF7-A8B7-57CC34A636F1

P407

Q28263653-2CC55926-ADC6-4EA5-BFA8-8A1EEA1DCA1B

P433

Q28263653-F9A8FC02-7137-4EA0-BBF3-81987209F0DD

P478

Q28263653-FAFE5547-EFE5-497A-BF9C-227D53D5B685

P577

Q28263653-37365590-59A6-4E4D-9686-B3357BBDBF66

P698

Q28263653-41D967E2-77BF-4461-8CE7-C5791D7A98F1

P356

JBC.273.10.5808

P1433

Journal of Biological Chemistry

P1476

Activation of OX40 signal tran ...... -mediated NF-kappaB activation

@en

P2093

A Imura

http://www.w3.org/2001/XMLSchema#string

A Takaori-Kondo

http://www.w3.org/2001/XMLSchema#string

S Kawamata

http://www.w3.org/2001/XMLSchema#string

T Hori

http://www.w3.org/2001/XMLSchema#string

T Uchiyama

http://www.w3.org/2001/XMLSchema#string

P2860

The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen

A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40

Involvement of CRAF1, a relative of TRAF, in CD40 signaling

A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death

TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation

Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma

TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways

Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells

P304

5808-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.273.10.5808

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

273

http://www.w3.org/2001/XMLSchema#string

P577

1998-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9488716

http://www.w3.org/2001/XMLSchema#string